Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer

NCT03326102 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent or Metastatic Breast Cancer

Interventions

DRUG: DHP107
DRUG: IV Paclitaxel

Sponsor

Daehwa Pharmaceutical Co., Ltd.